Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Endoscopic Retrograde Pancreatography | Case report

Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature

Authors: Wataru Koizumi, Minoru Kitago, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, Go Oshima, Shutaro Hori, Kenta Inomata, Hirofumi Kawakubo, Miho Kawaida, Yuko Kitagawa

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Oesophageal cancer has a high metastatic potential and poor prognosis, with a significant risk of recurrence after radical resection. However, resected pancreatic metastasis from oesophageal cancer is rare.

Case presentation

Eleven years prior, a seventy-year-old woman had been treated with transthoracic radical oesophagectomy for oesophageal squamous cell carcinoma. Four years prior, she had undergone chemotherapy for lymph node recurrence at the splenic hilum and achieved a partial response. She had also received chemoradiotherapy for lymph node recurrence at the splenic hilum 3 years prior; a complete response was achieved. However, routine follow-up with abdominal computed tomography recently revealed a tumour at the pancreatic tail and swollen lymph nodes. The patient underwent distal pancreatectomy on the basis of a pre-operative diagnosis of primary pancreatic cancer, although a histological examination of the surgical specimen revealed metastatic squamous cell carcinoma that was compatible with metachronous pancreatic metastasis from oesophageal squamous cell carcinoma. The patient has been undergoing clinical follow-up without adjuvant therapy and has been disease-free for 24 months after resection of the pancreatic metastasis.

Conclusions

Resection of pancreatic metastasis may improve prognosis and should be considered when treating patients with solitary metastasis from oesophageal squamous cell carcinoma.
Literature
1.
go back to reference Matsuda S, Takeuchi H, Kawakubo H, Ando N, Kitagawa Y. Current advancement in multidisciplinary treatment for resectable cStage II/III esophageal squamous cell carcinoma in Japan. Ann Thorac Cardiovasc Surg. 2016;22:275–83.CrossRef Matsuda S, Takeuchi H, Kawakubo H, Ando N, Kitagawa Y. Current advancement in multidisciplinary treatment for resectable cStage II/III esophageal squamous cell carcinoma in Japan. Ann Thorac Cardiovasc Surg. 2016;22:275–83.CrossRef
2.
go back to reference Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.CrossRef Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.CrossRef
3.
go back to reference Takeuchi M, Takeuchi H, Kawakubo H, Booka E, Mayanagi S, Fukuda K, et al. Perioperative risk calculator predicts long-term oncologic outcome for patients with esophageal carcinoma. Ann Surg Oncol. 2018;25:837–43.CrossRef Takeuchi M, Takeuchi H, Kawakubo H, Booka E, Mayanagi S, Fukuda K, et al. Perioperative risk calculator predicts long-term oncologic outcome for patients with esophageal carcinoma. Ann Surg Oncol. 2018;25:837–43.CrossRef
4.
go back to reference Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, et al. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology. 2014;86:336–9.CrossRef Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, et al. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology. 2014;86:336–9.CrossRef
5.
go back to reference Quint L, Hepburn L, Francis I, Whyte R, Orringer M. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.CrossRef Quint L, Hepburn L, Francis I, Whyte R, Orringer M. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.CrossRef
6.
go back to reference Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng J. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527–35.CrossRef Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng J. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527–35.CrossRef
7.
go back to reference Reddy S, Wolfgang C. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.CrossRef Reddy S, Wolfgang C. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.CrossRef
8.
go back to reference Masetti M, Zanini N, Martuzzi F, Fabbri C, Mastrangelo L, Landolfo G, et al. Analysis of prognostic factors in metastatic tumors of the pancreas: a single-center experience and review of the literature. Pancreas. 2010;39:135–43.CrossRef Masetti M, Zanini N, Martuzzi F, Fabbri C, Mastrangelo L, Landolfo G, et al. Analysis of prognostic factors in metastatic tumors of the pancreas: a single-center experience and review of the literature. Pancreas. 2010;39:135–43.CrossRef
9.
go back to reference Esfehani M, Mahmoodzadeh H, Alibakhshi A, Safavi F. Esophageal squamous cell carcinoma with pancreatic metastasis: a case report. Acta Med Iran. 2011;49:760–2.PubMed Esfehani M, Mahmoodzadeh H, Alibakhshi A, Safavi F. Esophageal squamous cell carcinoma with pancreatic metastasis: a case report. Acta Med Iran. 2011;49:760–2.PubMed
10.
go back to reference Park C, Jang JY, Kim YH, Hwang EJ, Na KY, Kim KY, et al. A case of esophageal squamous cell carcinoma with pancreatic metastasis. Clin Endosc. 2012;46:197–200.CrossRef Park C, Jang JY, Kim YH, Hwang EJ, Na KY, Kim KY, et al. A case of esophageal squamous cell carcinoma with pancreatic metastasis. Clin Endosc. 2012;46:197–200.CrossRef
11.
go back to reference Okamoto H, Hara Y, Chin M, Hagiwara M, Onodera Y, Horii S, et al. An extremely rare case of pancreatic metastasis of esophageal squamous cell carcinoma. World J Gastroenterol. 2014;20:593–7.CrossRef Okamoto H, Hara Y, Chin M, Hagiwara M, Onodera Y, Horii S, et al. An extremely rare case of pancreatic metastasis of esophageal squamous cell carcinoma. World J Gastroenterol. 2014;20:593–7.CrossRef
12.
go back to reference Nakamura E, Shimizu M, Itoh T, Manabe T. Secondary tumors of the pancreas: clinicopathological study of 103 autopsy cases of Japanese patients. Pathol Int. 2001;51:686–90.CrossRef Nakamura E, Shimizu M, Itoh T, Manabe T. Secondary tumors of the pancreas: clinicopathological study of 103 autopsy cases of Japanese patients. Pathol Int. 2001;51:686–90.CrossRef
13.
go back to reference Fujita Y, Kitago M, Masugi Y, Itano O, Shinoda M, Abe Y, et al. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol. 2016;22:9222–8.CrossRef Fujita Y, Kitago M, Masugi Y, Itano O, Shinoda M, Abe Y, et al. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol. 2016;22:9222–8.CrossRef
14.
go back to reference Varker K, Muscarella P, Wall K, Ellison C, Bloomston M. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World J Surg Oncol. 2007;5:145.CrossRef Varker K, Muscarella P, Wall K, Ellison C, Bloomston M. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World J Surg Oncol. 2007;5:145.CrossRef
Metadata
Title
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature
Authors
Wataru Koizumi
Minoru Kitago
Masahiro Shinoda
Hiroshi Yagi
Yuta Abe
Go Oshima
Shutaro Hori
Kenta Inomata
Hirofumi Kawakubo
Miho Kawaida
Yuko Kitagawa
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5549-9

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine